LONG-TERM TREATMENT OF HYPERLIPIDEMIC PATIENTS WITH CLOFIBRATE

被引：50
作者：
BERKOWITZ, D
机构：
来源：
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1971年 / 218卷 / 07期
关键词：
D O I：
10.1001/jama.218.7.1002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1002 / +
页数：1
相关论文
共 26 条
[1]  
ABELL LL, 1952, J BIOL CHEM, V195, P357
[2]   EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON SERUM LIPIDS FAT TOLERANCE AND URIC ACID [J].
BERKOWITZ, D .
METABOLISM, 1965, 14 (09) :966-+
[3]   EFFECTS OF CLOFIBRATE AND DEXTROTHYROXINE SINGLY AND IN COMBINATION ON SERUM LIPIDS [J].
BEST, MM ;
DUNCAN, CH .
ARCHIVES OF INTERNAL MEDICINE, 1966, 118 (02) :97-&
[4]   5-YEAR EXPERIENCE OF MODIFIED FAT DIETS ON YOUNGER MEN WITH CORONARY HEART DISEASE [J].
BIERENBAUM, ML ;
FLEISCHMAN, AI ;
GREEN, DP ;
RAICHELSON, RI ;
HAYTON, T ;
WATSON, PB ;
CALDWELL, AB .
CIRCULATION, 1970, 42 (05) :943-+
[5]  
CORNFIELD J, 1962, FED PROC, V21, P58
[6]   SELECTED RISK FACTORS IN CORONARY DISEASE - POSSIBLE INTERVENTION EFFECTS [J].
CORNFIELD, J ;
MITCHELL, S .
ARCHIVES OF ENVIRONMENTAL HEALTH, 1969, 19 (03) :382-+
[7]   SOME CLINICAL POTENTIALS OF CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE) THERAPY (HYPERLIPIDEMIA-ANGINA PECTORIS-BLOOD SLUDGING-DIABETIC NEUROPATHY) [J].
DUNCAN, GG ;
ELLIOTT, FA ;
DUNCAN, TG ;
SCHATANOFF, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1968, 17 (05) :457-+
[8]  
FAJANS SS, 1960, DIABETES, P389
[9]   FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONTINUED) [J].
FREDRICK.DS ;
LEVY, RI ;
LEES, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (03) :148-+
[10]   FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONCLUDED) [J].
FREDRICK.DS ;
LEVY, RI ;
LEES, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (05) :273-+
123